Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

ReNeuron unveils more encouraging data on stem cell line  


ReNeuron's ReN001 stem cell therapy is currently being used to treat disabled stroke patients as part of the ground-breaking PISCES Study being carried out in Scotland. The first patient has been treated for more than 12 months with no adverse ...Read More.​


Posted on 15-Mar-12 by Geier, Eric
Tags: Science and Industry News
Trackback Url  |  Link to this post | Bookmark this post with: